January 2025 Tender Results

Medicines Tender Closed

Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2024/25 Invitation to Tender dated 31 October 2024.

Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceutical under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:

  • For new listings, by 4pm on the 12th of February 2025 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode.

2024/25 Tender – Principal Supply Status applies until 30 June 2028

Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule

The decisions were as follows:

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

Date of subsidy change

Principal Supply date

Adrenaline

Inj 0.15 mg per 0.3 ml autoinjector; 1 Auto-injector pen OP

$90.00

$85.50

EpiPen Jr (Viatris)

1 July 2025

1 December 2025

Adrenaline

Inj 0.3 mg per 0.3 ml autoinjector; 1 Auto-injector pen OP

$90.00

$85.50

EpiPen (Viatris)

1 July 2025

1 December 2025

Budesonide

Cap modified-release 3 mg; 90 capsule bottle pack

$87.60

$33.38

Budesonide Te Arai (Te Arai)

1 July 2025

1 December 2025

Cetomacrogol with glycerol

Crm 90% with glycerol 10%; 500 ml pump bottle OP

$2.13

$1.92

Evara (Evara)

1 July 2025

1 December 2025

Cetomacrogol with glycerol

Crm 90% with glycerol 10%; 1,000 ml pump bottle OP

$3.50

$3.25

Evara (Evara)

1 July 2025

1 December 2025

Compound electrolytes

Powder for oral soln; 50 sachet carton

$9.53

$9.50

Electral (Teva)

1 July 2025

1 December 2025

Domperidone

Tab 10 mg; 100 tablet blister pack

$4.00

$3.80

Domperidone Viatris (Viatris)

1 July 2025

1 December 2025

Fludrocortisone acetate

Tab 100 mcg; 100 tablet bottle pack

$11.46

$8.05

Florinef (Aspen)

1 July 2025

1 December 2025

Iloprost

Nebuliser soln 10 mcg per ml, 2 ml; 30 glass ampoules

$185.03

$166.53

Vebulis (Devatis)

1 July 2025

1 December 2025

Mercaptopurine

Tab 50 mg; 25 tablet bottle pack

$25.90

$19.50

Puri-nethol (Aspen)

1 July 2025

1 December 2025

Montelukast

Tab 4 mg; 28 tablet blister pack

$3.10

$3.10

Montelukast Viatris (Viatris)

1 July 2025

1 December 2025

Montelukast

Tab 5 mg; 28 tablet blister pack

$3.10

$3.10

Montelukast Viatris (Viatris)

1 July 2025

1 December 2025

Montelukast

Tab 10 mg; 28 tablet blister pack

$2.90

$2.45

Montelukast Viatris (Viatris)

1 July 2025

1 December 2025

Ondansetron1

Tab 4 mg; 50 tablet blister pack

$2.27

$1.95

Periset (Miro)

1 July 2025

1 December 2025

Ondansetron1

Tab 8 mg; 50 tablet blister pack

$4.10

$3.50

Periset (Miro)

1 July 2025

1 December 2025

Posaconazole

Oral liq 40 mg per ml; 105 ml bottle OP

$342.51

$308.26

Devatis (Devatis)

1 July 2025

1 December 2025

Posaconazole

Tab modified release 100 mg; 24 tablet blister pack

$206.00

$123.60

Posaconazole Juno (Arrotex)

1 July 2025

1 December 2025

Pramipexole hydrochloride1

Tab 0.25 mg; 100 tablet blister pack

$5.51

$5.23

Ramipex (Devatis)

1 July 2025

1 December 2025

Pramipexole hydrochloride1

Tab 1 mg; 100 tablet blister pack

$18.66

$17.73

Ramipex (Devatis)

1 July 2025

1 December 2025

Tenofovir disoproxil

Tab 245 mg (300 mg as a maleate); 30 tablet bottle pack

$15.00

$13.80

Tenofovir Disoproxil Viatris (Viatris)

1 July 2025

1 December 2025

Trimethoprim with sulphamethoxazole [co-trimoxazole]

Oral liq 8 mg sulphamethoxazole 40 mg per ml, 100 ml bottle

$5.00

$4.95

Deprim (AFT)

1 March 2025

1 August 2025

Voriconazole

Tab 50 mg; 56 tablet blister pack

$91.00

$71.00

Vttack (Viatris)

1 March 2025

1 August 2025

Voriconazole

Tab 200 mg; 56 tablet blister pack

$350.00

$263.00

Vttack (Viatris)

1 March 2025

1 August 2025

1This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender.

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

Listing date

Principal Supply date

Brand (Supplier) (Pharmacode) affected by delisting

Promethazine hydrochloride

Tab 10 mg; 100 tablet blister pack

$1.39 (per 50)

$2.19

Allersoothe (AFT)

1 July 2025

1 December 2025

Allersoothe (AFT) (2238098)

Promethazine hydrochloride

Tab 25 mg; 100 tablet blister pack

$1.58 (per 50)

$2.69

Allersoothe (AFT)

1 July 2025

1 December 2025

Allersoothe (AFT) (2238128)

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.

3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

DV Limit

Listing date

Principal Supply date

Adrenaline

Inj 0.15 mg per 0.3 ml autoinjector; 1 Auto-injector pen

$90.00

$85.50

EpiPen Jr (Viatris)

5%

1 July 2025

1 December 2025

Adrenaline

Inj 0.3 mg per 0.3 ml autoinjector; 1 Auto-injector pen

$90.00

$85.50

EpiPen (Viatris)

5%

1 July 2025

1 December 2025

Budesonide

Cap modified-release 3 mg; 90 capsule bottle pack

$87.60

$33.38

Budesonide Te Arai (Te Arai)

5%

1 July 2025

1 December 2025

Bupivacaine hydrochloride with glucose

Inj 0.5% with glucose 8%, 4 ml ampoule; 5 ampoule pack

$26.67

$21.40

Marcain Heavy (Aspen)

5%

1 July 2025

1 December 2025

Cetomacrogol with glycerol

Crm 90% with glycerol 10%; 500 ml pump bottle

$2.13

$1.92

Evara (Evara)

5%

1 July 2025

1 December 2025

Cetomacrogol with glycerol

Crm 90% with glycerol 10%; 1,000 ml pump bottle

$3.50

$3.25

Evara (Evara)

5%

1 July 2025

1 December 2025

Compound electrolytes

Powder for oral soln; 50 sachet carton

$9.53

$9.50

Electral (Teva)

5%

1 July 2025

1 December 2025

Domperidone

Tab 10 mg; 100 tablet blister pack

$4.00

$3.80

Domperidone Viatris (Viatris)

5%

1 July 2025

1 December 2025

Fludrocortisone acetate

Tab 100 mcg; 100 tablet bottle pack

$11.46

$8.05

Florinef (Aspen)

5%

1 July 2025

1 December 2025

Iloprost

Nebuliser soln 10 mcg per ml, 2 ml; 30 glass ampoules

$185.03

$166.53

Vebulis (Devatis)

5%

1 July 2025

1 December 2025

Mercaptopurine

Tab 50 mg; 25 tablet bottle pack

$25.90

$19.50

Puri-nethol (Aspen)

5%

1 July 2025

1 December 2025

Montelukast

Tab 4 mg; 28 tablet blister pack

$3.10

$3.10

Montelukast Viatris (Viatris)

5%

1 July 2025

1 December 2025

Montelukast

Tab 5 mg; 28 tablet blister pack

$3.10

$3.10

Montelukast Viatris (Viatris)

5%

1 July 2025

1 December 2025

Montelukast

Tab 10 mg; 28 tablet blister pack

$2.90

$2.45

Montelukast Viatris (Viatris)

5%

1 July 2025

1 December 2025

Ondansetron2

Tab 4 mg; 50 tablet blister pack

$2.27

$1.95

Periset (Miro)

5%

1 July 2025

1 December 2025

Ondansetron2

Tab 8 mg; 50 tablet blister pack

$4.10

$3.50

Periset (Miro)

5%

1 July 2025

1 December 2025

Piperacillin with tazobactam

Inj 4 g with tazobactam 0.5 g vial; 1 vial pack

$3.59

$3.15

PipTaz-AFT (AFT)

5%

1 July 2025

1 December 2025

Posaconazole

Oral liq 40 mg per ml; 105 ml bottle

$342.51

$308.26

Devatis (Devatis)

5%

1 July 2025

1 December 2025

Posaconazole

Tab modified release 100 mg; 24 tablet blister pack

$206.00

$123.60

Posaconazole Juno (Arrotex)

5%

1 July 2025

1 December 2025

Pramipexole hydrochloride2

Tab 0.25 mg; 100 tablet blister pack

$5.51

$5.23

Ramipex (Devatis)

5%

1 July 2025

1 December 2025

Pramipexole hydrochloride2

Tab 1 mg; 100 tablet blister pack

$18.66

$17.73

Ramipex (Devatis)

5%

1 July 2025

1 December 2025

Tenofovir disoproxil

Tab 245 mg (300 mg as a maleate); 30 tablet bottle pack

$15.00

$13.80

Tenofovir Disoproxil Viatris (Viatris)

5%

1 July 2025

1 December 2025

Trimethoprim with sulphamethoxazole [co-trimoxazole]

Oral liq 8 mg sulphamethoxazole 40 mg per ml, 100 ml bottle

$5.00

$4.95

Deprim (AFT)

5%

1 March 2025

1 August 2025

Voriconazole

Inj 200 mg vial; 1 vial pack

$19.85

$16.89

AFT (AFT)

5%

1 July 2025

1 December 2025

Voriconazole

Tab 50 mg; 56 tablet blister pack

$91.00

$71.00

Vttack (Viatris)

5%

1 March 2025

1 August 2025

Voriconazole

Tab 200 mg; 56 tablet blister pack

$350.00

$263.00

Vttack (Viatris)

5%

1 March 2025

1 August 2025

2This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender.

4. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

DV Limit

Listing date

Principal Supply date

Brand (Supplier) (Pharmacode) affected by delisting

Promethazine hydrochloride

Tab 10 mg; 100 tablet blister pack

$1.39 (per 50)

$2.19

Allersoothe (AFT)

5%

1 July 2025

1 December 2025

Allersoothe (AFT) (2238098)

Promethazine hydrochloride

Tab 25 mg; 100 tablet blister pack

$1.58 (per 50)

$2.69

Allersoothe (AFT)

5%

1 July 2025

1 December 2025

Allersoothe (AFT) (2238128)

Tender declines – Products where no tender is to be awarded for Principal Supply Status

Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2023/24 Invitation to Tender, dated 31 October 2023.

Chemical Name

Line Item

Disulfiram

Tab 200 mg

Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2024/25 Invitation to Tender, dated 31 October 2024.

Chemical Name

Line Item

Colestyramine

Powder for oral liq 4 g

Dipyridamole

Tab or cap long-acting 150 mg

Famotidine

Inj 10 mg per ml, 2 ml

Famotidine

Inj 10 mg per ml, 4 ml

Famotidine

Tab 20 mg

Famotidine

Tab 40 mg

Fludarabine phosphate

Inj 50 mg

Fludarabine phosphate

Tab 10 mg

Labetalol

Tab 100 mg

Labetalol

Tab 200 mg

Lithium carbonate

Cap 250 mg

Prazosin hydrochloride

Tab 1 mg

Prazosin hydrochloride

Tab 2 mg

Prazosin hydrochloride

Tab 5 mg

Preservative free ophthalmic

Gel

Sodium hypochlorite

Soln 5% 1,000 – 2,500 ml

For products included in the 2022/23, 2023/24 and 2024/25 Invitation to Tender where no announcement has yet been made, a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.